$21.40
0[0.00%]
Last update: 12:34PM Get Real Time Here
Fusion Pharmaceuticals: Insider buying and selling updated today.
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
---|---|---|---|---|---|---|---|---|---|---|
Aug 11, 2022 | Steve Gannon | DIRECTOR | 44.4K | $2.03 | $90.13K | BUY | 370.00% | 56.4K | Aug 11 | View |
Apr 27, 2022 | John Valliant | CHIEF EXECUTIVE OFFICER | -8.694K | $6.04 | -$52.51K | SELL | -2.66% | 318.147K | Apr 25 - Apr 27 | View |
Apr 22, 2022 | John Valliant | CHIEF EXECUTIVE OFFICER | -1.289K | $6.01 | -$7.75K | SELL | -0.39% | 326.841K | Apr 20 - Apr 21 | View |
Apr 13, 2022 | John Valliant | CHIEF EXECUTIVE OFFICER | -32.849K | $6.87 | -$225.65K | SELL | -9.10% | 328.13K | Apr 11 - Apr 13 | View |
Apr 08, 2022 | John Valliant | CHIEF EXECUTIVE OFFICER | -2.181K | $7.55 | -$16.46K | SELL | -0.60% | 360.979K | Apr 06 - Apr 08 | View |
Apr 05, 2022 | John Valliant | CHIEF EXECUTIVE OFFICER | -3.8K | $7.72 | -$29.32K | SELL | -1.04% | 363.16K | Apr 01 - Apr 05 | View |
Apr 01, 2022 | John Valliant | CHIEF EXECUTIVE OFFICER | -300 | $7.52 | -$2.26K | SELL | -0.08% | 366.96K | Mar 30 | View |
Mar 29, 2022 | John Valliant | CHIEF EXECUTIVE OFFICER | -10.3K | $7.54 | -$77.69K | SELL | -2.73% | 367.26K | Mar 25 - Mar 29 | View |
Mar 24, 2022 | John Valliant | CHIEF EXECUTIVE OFFICER | -4.8K | $7.52 | -$36.09K | SELL | -1.26% | 377.56K | Mar 21 - Mar 23 | View |
Mar 21, 2022 | John Valliant | CHIEF EXECUTIVE OFFICER | -3.604K | $7.53 | -$27.13K | SELL | -0.93% | 382.36K | Mar 17 - Mar 21 | View |
Mar 16, 2022 | John Valliant | CHIEF EXECUTIVE OFFICER | -1.5K | $6.97 | -$10.46K | SELL | -0.39% | 385.964K | Mar 14 - Mar 16 | View |
Mar 14, 2022 | John Valliant | CHIEF EXECUTIVE OFFICER | -2.822K | $7.03 | -$19.83K | SELL | -0.72% | 387.464K | Mar 09 - Mar 11 | View |
Mar 08, 2022 | John Valliant | CHIEF EXECUTIVE OFFICER | -14.504K | $7.17 | -$103.94K | SELL | -3.58% | 390.286K | Mar 04 - Mar 08 | View |
Mar 03, 2022 | John Valliant | CHIEF EXECUTIVE OFFICER | -27.593K | $7.44 | -$205.20K | SELL | -6.38% | 404.79K | Mar 01 - Mar 03 | View |
Feb 28, 2022 | John Valliant | CHIEF EXECUTIVE OFFICER | -13.752K | $7.50 | -$103.18K | SELL | -3.08% | 432.383K | Feb 24 - Feb 28 | View |
Feb 23, 2022 | John Valliant | CHIEF EXECUTIVE OFFICER | -38.297K | $7.79 | -$298.43K | SELL | -7.91% | 446.135K | Feb 18 - Feb 23 | View |
Feb 17, 2022 | John Valliant | CHIEF EXECUTIVE OFFICER | -47.502K | $8.08 | -$383.81K | SELL | -8.93% | 484.432K | Feb 15 - Feb 17 | View |
Aug 23, 2021 | Steve Gannon | DIRECTOR | 2.829K | $7.99 | $22.59K | BUY | 30.85% | 12K | Aug 23 | View |
Aug 20, 2021 | Steve Gannon | DIRECTOR | 3.171K | $8.05 | $25.53K | BUY | 52.85% | 9.171K | Aug 18 - Aug 19 | View |
Browse insider trades on all stocks.